Your browser doesn't support javascript.
loading
Listeria monocytogenes bacteremia developed during treatment of COVID-19.
Yamamoto, Jin; Nakamoto, Keitaro; Shimasaki, Teppei; Kurai, Daisuke; Saraya, Takeshi; Ishii, Haruyuki.
Affiliation
  • Yamamoto J; Department of Nephrology and Rheumatology Kyorin University School of Medicine Mitaka Tokyo Japan.
  • Nakamoto K; Department of Respiratory Medicine Kyorin University School of Medicine Mitaka Tokyo Japan.
  • Shimasaki T; Department of General Medicine Kyorin University School of Medicine Mitaka Tokyo Japan.
  • Kurai D; Department of General Medicine Kyorin University School of Medicine Mitaka Tokyo Japan.
  • Saraya T; Department of Respiratory Medicine Kyorin University School of Medicine Mitaka Tokyo Japan.
  • Ishii H; Department of Respiratory Medicine Kyorin University School of Medicine Mitaka Tokyo Japan.
Clin Case Rep ; 11(11): e8115, 2023 Nov.
Article in En | MEDLINE | ID: mdl-37908788
ABSTRACT
Listeria monocytogenes is an important pathogen in older patients and immunosuppressed patients, often causing bacteremia. Complications resulting from infections other than COVID-19 must also be considered during COVID-19 treatment.
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Case Rep Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Case Rep Year: 2023 Document type: Article